← All organizations

Genelux

For profitWebsite ↗

Also known as: Genelux Corporation | Genelux GmbH

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 26, 2024

Timeline

2000s

Jun 1, 2001
Genelux— Founded

Drugs by trial phase (16 distinct, 10 trials)

Phase 3 (8 own, 0 via acquisition)

Phase 2 (8 own, 0 via acquisition)

Indications

Studied for

Recent trials (10)

NCT03420430Lead sponsorN/A—
NCT06463665Lead sponsorPhase 2Sep 26, 2024
NCT07136285CollaboratorPhase 1/Phase 2Jul 24, 2023
NCT05281471Lead sponsorPhase 3Aug 31, 2022
NCT02759588Lead sponsorPhase 1May 1, 2016
NCT02714374CollaboratorPhase 1Mar 1, 2016
NCT01766739CollaboratorPhase 1Jan 1, 2013
NCT01584284Lead sponsorPhase 1Apr 1, 2012
NCT01443260Lead sponsorPhase 1/Phase 2Feb 1, 2012
NCT00794131Lead sponsorPhase 1Nov 1, 2008

Details

Founded: San Diego, CA, US Jun 1, 2001
Last known activity: Sep 26, 2024